The mainstay of therapy for<unk>  in immunocompromised patients is highly active antiretroviral therapy (HAART). Albendazole and fumagillin have demonstrated consistent activity against other microsporidia in vitro and in vivo.
Microsporidiosis medical therapy
Cyclosporiasis medical therapy
Psittacosis medical therapy
Bartonellosis medical therapy
Leishmaniasis medical therapy
Enterobiasis medical therapy
Histoplasmosis medical therapy
Listeriosis medical therapy